Details for New Drug Application (NDA): 074817
✉ Email this page to a colleague
The generic ingredient in INVAGESIC FORTE is aspirin; caffeine; orphenadrine citrate. There are twenty-two drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the aspirin; caffeine; orphenadrine citrate profile page.
Summary for 074817
Tradename: | INVAGESIC FORTE |
Applicant: | Sandoz |
Ingredient: | aspirin; caffeine; orphenadrine citrate |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 385MG;30MG;25MG | ||||
Approval Date: | Nov 27, 1996 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 770MG;60MG;50MG | ||||
Approval Date: | Nov 27, 1996 | TE: | RLD: | No |
Complete Access Available with Subscription